Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWBNTX is a δ1-opioid receptor antagonist (Ki = 0.1 nM).1 It is selective for the δ1-opioid receptor over the δ2-, μ-, and κ-opioid receptors (Kis = 10.8, 13.3, and 58.6 nM, respectively). BNTX (1 and 10 µM) decreases proliferation of primary mouse splenic B cells and the production of IL-2 and IL-4 by primary mouse splenic T lymphocytes.2 It has antinociceptive activity in the tail-flick test in mice (ED50 = 46.4 pmol/animal) and decreases the antinociceptive activity of the δ1-opioid receptor agonist DPDPE (Item No. 23184) when administered at a dose of 6.3 pmol/animal.1 BNTX (0.3-3 mg/kg) decreases the number of coughs induced by the terpene alkaloid capsaicin (Item No. 92350) in mice.3 It also reduces the number of parasitized red blood cells in a mouse model of chloroquine-resistant P. chabaudi infection when administered at a dose of 10 mg/kg.4
WARNING This product is not for human or veterinary use.
1. A highly selective δ1-
2. Suppression of immune function by non-
3. Involvement of δ1-
4. Opioid δ₁ receptor antagonist 7-